Jain Rita 4
4 · Avalo Therapeutics, Inc. · Filed Jan 5, 2026
Insider Transaction Report
Form 4
Jain Rita
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-12-31$14.74/sh+1,043$15,374→ 1,043 totalExercise: $18.16Exp: 2035-12-31→ Common Stock (1,043 underlying)
Footnotes (1)
- [F1]The options were granted on December 31, 2025, and are 100% vested.